At diagnosis, the following data were available: age, sex, stage, histological grade, "B" symptoms, number of affected lymph node regions, extranodal involvement, bone marrow infiltration, performance status, bulky disease, detection of Hepatitis C Virus, standard hematological tests and levels of LDH, β2-microglobulin and albumin.
In murine models of leukemia, the EPA metabolite 15d-PGJ3 selectargetedargeted leukemia stem cells (LSCs) for apoptosis in the spleen and bone marrow, displaying superior performance compared to available chemotherapeutic approaches [ 15].
The other case study 29 aimed to evaluate the influence of a training programme on changes in serum monoclonal protein level, percentage of bone marrow plasma cells, fitness performance and cardiac autonomic control.
Patients were required to have adequate organ and bone marrow function, a European Cooperative Oncology Group performance status of 0 1, and a cardiac ejection fraction of at least 50%% (measured by echocardiogram or multigated acquisition scan).
The presence of two or more of these features triggered the performance of bone marrow aspiration and biopsy.
This study investigated regional differences in the performance of bone marrow transplantation (BMT), outcome and care-resource use in patients with ATL in Japan.
A national study of the performance of bone marrow examination in newly diagnosed Hodgkin's disease was undertaken to establish current practice.
Although, the National Healthcare Safety Network (NHSN) definition for CLABSI has been applied extensively in intensive care units, few studies have examined its performance among bone marrow transplant (BMT) recipients.
Patients records were reviewed to obtain baseline characteristic at the time of diagnosis (clinical stage, presence of B symptoms, performance status, bone marrow involvement, involvement of extranodal sites, mediastinal lymph node involvement, LDH, IPI score, PIT score).
The association between B symptoms and leucopenia persisted (OR 1.7, 95% CI 1.2 2.4) in multivariate analysis after adjustment for age, performance status, bone marrow involvement, type of chemotherapy and receipt of GCSF, the latter having a protective effect (Table 5).
After providing informed consent, study patients underwent baseline tests which included physical examination, vital signs, ECOG performance status, bone marrow aspirate and biopsy, positron emission tomography and computed tomography scan, revised IPI score documentation, electrocardiography, hematology and serum chemistry panels, hepatitis B screening, and pregnancy test.
